Immunohistochemical localization of follicle-stimulating hormone, luteinizing hormone, growth hormone, adrenocorticotrophic hormone and prolactin in the human placenta

Placenta ◽  
1986 ◽  
Vol 7 (2) ◽  
pp. 163-172 ◽  
Author(s):  
A. Al-Timimi ◽  
H. Fox
1968 ◽  
Vol 46 (4) ◽  
pp. 639-647
Author(s):  
J. K. Davidson ◽  
R. E. Haist

The effects of various levels of several substrates and hormones on the glycogen content of mouse hemidiaphragm in vitro in the presence and absence of insulin were determined. Pyruvate (0.64 mg/ml) increased glycogen. Acetoacetate (0.16 mg/ml), β-hydroxybutyrate (2.5 mg/ml), and lactate (2.5 mg/ml) increased glycogen only in the presence of glucose and insulin. A mixture of 19 amino acids (0.2 mg/ml of each) had no effect. Growth hormone (100 μg/ml) had no effect in the absence of insulin, but increased glycogen in the presence of glucose and insulin. Prolactin, thyrotrophin, luteinizing hormone, follicle-stimulating hormone, oxytocin, thyroxine, triiodothyronine, cysteine-treated glucagon, adrenocorticotrophic hormone (512 μg/ml), vasopressin (5.25 μg/ml), and Cortisol (16 μg/ml) had no effect. Epinephrine (0.01 μg/ml) and norepinephrine (0.1 μg/ml) had no effect, but epinephrine (0.1 μg/ml) and norepinephrine (1 μg/ml) decreased glycogen content. At physiologic levels of the tested materials, only glucose and insulin altered the glycogen content of mouse hemidiaphragm.


Author(s):  
Mone Zaidi ◽  
Li Sun ◽  
Peng Liu ◽  
Terry F. Davies ◽  
Maria New ◽  
...  

AbstractPituitary hormones have traditionally been thought to exert specific, but limited function on target tissues. More recently, the discovery of these hormones and their receptors in organs such as the skeleton suggests that pituitary hormones have more ubiquitous functions. Here, we discuss the interaction of growth hormone (GH), follicle stimulating hormone (FSH), thyroid stimulating hormone (TSH), adrenocorticotrophic hormone (ACTH), prolactin, oxytocin and arginine vasopressin (AVP) with bone. The direct skeletal action of pituitary hormones therefore provides new insights and therapeutic opportunities for metabolic bone diseases, prominently osteoporosis.


1973 ◽  
Vol 73 (3) ◽  
pp. 465-474 ◽  
Author(s):  
Egil Haug ◽  
Peter Torjesen

ABSTRACT Four normal male subjects received iv injections of synthetic luteinizing hormone- and follicle stimulating hormone-releasing hormone (LH/FSH-RH) in doses of 12.5, 25, 100, 200 and 400 μg, respectively. A dose of 12.5 μg of LH/FSH-RH caused a significant increase in serum FSH, and 25 μg significantly increased the serum LH. The peak responses occurred 15 to 30 min after the LH/FSH-RH injections in most of the experiments. The increase in the mean maximum serum LH and FSH levels was 2 to 4 fold. There was great variation in response between the subjects, but when tested repeatedly with the same dose of LH/FSH-RH a given individual responded in a consistent manner. The log dose-response curve between LH/FSH-RH and serum LH, and between LH/FSH-RH and serum FSH was approximately linear. A small but significant (P < 0.05) rise in serum thyrotrophin (TSH) was found after LH/FSH-RH in doses ranging from 25 to 400 μg. There was no significant rise in serum growth hormone (HGH). On the basis of the present study a standard 100 μg iv LH/FSH-RH test is suggested.


Sign in / Sign up

Export Citation Format

Share Document